设为首页 加入收藏

TOP

KANJINTI 420 mg powder for concentrate for solution for infusion(十)
2019-06-14 12:25:56 来源: 作者: 【 】 浏览:11647次 评论:0

Very common
1Palpitation
Very common
1Cardiac flutter
Very common
Ejection fraction decreased*
Very common
+Cardiac failure (congestive)
Common
+1Supraventricular tachyarrhythmia
Common
Cardiomyopathy
Common
Pericardial effusion
Uncommon
Cardiogenic shock
Not known
Pericarditis
Not known
Bradycardia
Not known
Gallop rhythm present
Not known
Vascular disorders
Hot flush
Very common
+1Hypotension
Common
Vasodilatation
Common
Respiratory, thoracic and mediastinal disorders
+1Wheezing
Very common
+Dyspnoea
Very common
Cough
Very common
Epistaxis
Very common
Rhinorrhoea
Very common
+Pneumonia
Common
Asthma
Common
Lung disorder
Common
+Pleural effusion
Common
Pneumonitis
Rare
+Pulmonary fibrosis
Not known
+Respiratory distress
Not known
+Respiratory failure
Not known
+Lung infiltration
Not known
+Acute pulmonary oedema
Not known
+Acute respiratory distress syndrome
Not known
+Bronchospasm
Not known
+Hypoxia
Not known
+Oxygen saturation decreased
Not known
Laryngeal oedema
Not known
Orthopnoea
Not known
Pulmonary oedema
Not known
Interstitial lung disease
Not known
Gastrointestinal disorders
Diarrhoea
Very common
Vomiting
Very common
Nausea
Very common
1Lip swelling
Very common
Abdominal pain
Very common
Dyspepsia
Very common
Constipation
Very common
Stomatitis
Very common
Haemorrhoids
Common
Dry mouth
Common
Hepatobiliary disorders
Hepatocellular injury
Common
Hepatitis
Common
Liver tenderness
Common
Jaundice
Rare
Hepatic failure
Not known
Skin and subcutaneous tissue disorders
Erythema
Very common
Rash
Very common
1Swelling face
Very common
Alopecia
Very common
Nail disorder
Very common
Palmar-plantar erythrodysaesthesia syndrome
Very common
Acne
Common
Dry skin
Common
Ecchymosis
Common
Hyperhydrosis
Common
Maculopapular rash
Common
Pruritus
Common
Onychoclasis
Common
Dermatitis
Common
Urticaria
Uncommon
Angioedema
Not known
Musculoskeletal and connective tissue disorders
Arthralgia
Very common
1Muscle tightness
Very common
Myalgia
Very common
Arthritis
Common
Back pain
Common
Bone pain
Common
Muscle spasms
Common
Neck Pain
Common
Pain in extremity
Common
Renal and urinary disorders
Renal disorder
Common
Glomerulonephritis membranous
Not known
Glomerulonephropathy
Not known
Renal failure
Not known
Pregnancy, puerperium and perinatal conditions
Oligohydramnios
Not known
Renal hypoplasia
Not known
Pulmonary hypoplasia
Not known
Reproductive system and breast disorders
Breast inflammation/mastitis
Common
General disorders and administration site conditions
Asthenia
Very common
Chest pain
Very common
Chills
Very common
Fatigue
Very common
Influenza-like symptoms
Very common
Infusion-related reaction
Very common
Pain
Very common
Pyrexia
Very common
Mucosal inflammation
Very common
Peripheral oedema
Very common
Malaise
Common
Oedema
Common
Injury, poisoning and procedural complications
Contusion
Common
+ Denotes adverse reactions that have been reported in association with a fatal outcome.
1 Denotes adverse reactions t
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 7 8 9 10 11 12 13 下一页 尾页 10/25/25
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇KANJINTI 150 mg powder for conc.. 下一篇ZINPLAVA 25 mg/mL concentrate f..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位